These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 28302026)

  • 1. Drug Metabolism in Preclinical Drug Development: A Survey of the Discovery Process, Toxicology, and Computational Tools.
    Issa NT; Wathieu H; Ojo A; Byers SW; Dakshanamurthy S
    Curr Drug Metab; 2017; 18(6):556-565. PubMed ID: 28302026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico toxicology for the pharmaceutical sciences.
    Valerio LG
    Toxicol Appl Pharmacol; 2009 Dec; 241(3):356-70. PubMed ID: 19716836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational toxicology in drug development.
    Muster W; Breidenbach A; Fischer H; Kirchner S; Müller L; Pähler A
    Drug Discov Today; 2008 Apr; 13(7-8):303-10. PubMed ID: 18405842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploratory drug safety: a discovery strategy to reduce attrition in development.
    Bass AS; Cartwright ME; Mahon C; Morrison R; Snyder R; McNamara P; Bradley P; Zhou YY; Hunter J
    J Pharmacol Toxicol Methods; 2009; 60(1):69-78. PubMed ID: 19422924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical pharmacokinetics: an approach towards safer and efficacious drugs.
    Singh SS
    Curr Drug Metab; 2006 Feb; 7(2):165-82. PubMed ID: 16472106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent Advances of Computational Modeling for Predicting Drug Metabolism: A Perspective.
    Kar S; Leszczynski J
    Curr Drug Metab; 2017; 18(12):1106-1122. PubMed ID: 28595533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational science in drug metabolism and toxicology.
    Valerio LG
    Expert Opin Drug Metab Toxicol; 2010 Jul; 6(7):781-4. PubMed ID: 20465524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of computational structure-based predictive toxicology in drug discovery.
    Mohan CG
    Comb Chem High Throughput Screen; 2011 Jun; 14(5):417-26. PubMed ID: 21470184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3D bioprinting for drug discovery and development in pharmaceutics.
    Peng W; Datta P; Ayan B; Ozbolat V; Sosnoski D; Ozbolat IT
    Acta Biomater; 2017 Jul; 57():26-46. PubMed ID: 28501712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-dimensional (2D) in silico models for absorption, distribution, metabolism, excretion and toxicity (ADME/T) in drug discovery.
    Khakar PS
    Curr Top Med Chem; 2010; 10(1):116-26. PubMed ID: 19929825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Troubleshooting computational methods in drug discovery.
    Kortagere S; Ekins S
    J Pharmacol Toxicol Methods; 2010; 61(2):67-75. PubMed ID: 20176118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular clinical safety intelligence: a system for bridging clinically focused safety knowledge to early-stage drug discovery - the GSK experience.
    Vanderwall DE; Yuen N; Al-Ansari M; Bailey J; Fram D; Green DV; Pickett S; Vitulli G; Luengo JI; Almenoff JS
    Drug Discov Today; 2011 Aug; 16(15-16):646-53. PubMed ID: 21601652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methodologies for investigating drug metabolism at the early drug discovery stage: prediction of hepatic drug clearance and P450 contribution.
    Emoto C; Murayama N; Rostami-Hodjegan A; Yamazaki H
    Curr Drug Metab; 2010 Oct; 11(8):678-85. PubMed ID: 20973757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of predictive metabolism and toxicity modeling in drug discovery--a summary of some recent advancements.
    Wilson AG; White AC; Mueller RA
    Curr Opin Drug Discov Devel; 2003 Jan; 6(1):123-8. PubMed ID: 12613284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico ADME-Tox modeling: progress and prospects.
    Alqahtani S
    Expert Opin Drug Metab Toxicol; 2017 Nov; 13(11):1147-1158. PubMed ID: 28988506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are meaningful predictions of toxicological outcomes in clinical trials based on in vitro diagnostics of preclinical drug candidates possible?
    Kroll F; Dreger M
    Future Med Chem; 2010 Nov; 2(11):1613-7. PubMed ID: 21428831
    [No Abstract]   [Full Text] [Related]  

  • 17. In silico approaches to predicting drug metabolism, toxicology and beyond.
    Ekins S
    Biochem Soc Trans; 2003 Jun; 31(Pt 3):611-4. PubMed ID: 12773166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In silico toxicology models and databases as FDA Critical Path Initiative toolkits.
    Valerio LG
    Hum Genomics; 2011 Mar; 5(3):200-7. PubMed ID: 21504870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic properties and in silico ADME modeling in drug discovery.
    Honório KM; Moda TL; Andricopulo AD
    Med Chem; 2013 Mar; 9(2):163-76. PubMed ID: 23016542
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.